O Serce Pehlevan1, G Karatekin1, V Koksal2, D Benzer1, T Gursoy1, T Yavuz3, F Ovali1. 1. Zeynep Kamil Maternity and Children's Training and Research Hospital, Neonatology Unit, Istanbul, Turkey. 2. Burc Genetic Diagnosis Center, Istanbul, Turkey. 3. Zeynep Kamil Maternity and Children's Training and Research Hospital, Pediatric Cardiology Unit, Istanbul, Turkey.
Abstract
OBJECTIVE: The pathophysiologies of bronchopulmonary dysplasia (BPD) are inflammation, infection, tissue damage, angiogenesis defects and genetic susceptibility. Because of the role of the vitamin D binding protein (Gc globulin) on these factors, we investigated the relationship between Gc globulin polymorphisms and BPD. STUDY DESIGN: This case-control study was performed with 160 neonates (⩽32 gestational ages, ⩽1500 g). PCR DNA sequence analyses were used for GC gene rs4588 and rs7041 single-nucleotide polymorphisms. RESULT: In the univariate analyses, it was observed that Gc2 was the only variant that was protective against BPD (Odd ratio (OR)=0.47, 95% coinfidence interval (CI)=0.24 to 0.89, P=0.020). In the multivariate analyses, Gc2 decreased the risk of disease (OR=0.15, 95% CI=0.029 to 0.79, P=0.026) independent of gestational age, birth weight, 5-min Appearance, Pulse, Grimace, Activity, and Respiration scores, respiratory distress syndrome and sepsis. CONCLUSION: The Gc2 variant was, after adjusting for confounders, associated with a decrease in the frequency of BPD. Our study adds Gc globulin to the list of candidate genes that potentially contribute to the etiology of the disease.
OBJECTIVE: The pathophysiologies of bronchopulmonary dysplasia (BPD) are inflammation, infection, tissue damage, angiogenesis defects and genetic susceptibility. Because of the role of the vitamin D binding protein (Gc globulin) on these factors, we investigated the relationship between Gc globulin polymorphisms and BPD. STUDY DESIGN: This case-control study was performed with 160 neonates (⩽32 gestational ages, ⩽1500 g). PCR DNA sequence analyses were used for GC gene rs4588 and rs7041 single-nucleotide polymorphisms. RESULT: In the univariate analyses, it was observed that Gc2 was the only variant that was protective against BPD (Odd ratio (OR)=0.47, 95% coinfidence interval (CI)=0.24 to 0.89, P=0.020). In the multivariate analyses, Gc2 decreased the risk of disease (OR=0.15, 95% CI=0.029 to 0.79, P=0.026) independent of gestational age, birth weight, 5-min Appearance, Pulse, Grimace, Activity, and Respiration scores, respiratory distress syndrome and sepsis. CONCLUSION: The Gc2 variant was, after adjusting for confounders, associated with a decrease in the frequency of BPD. Our study adds Gc globulin to the list of candidate genes that potentially contribute to the etiology of the disease.
Authors: E M Hollams; P H Hart; B J Holt; M Serralha; F Parsons; N H de Klerk; G Zhang; P D Sly; P G Holt Journal: Eur Respir J Date: 2011-05-12 Impact factor: 16.671
Authors: A J Bhatt; G S Pryhuber; H Huyck; R H Watkins; L A Metlay; W M Maniscalco Journal: Am J Respir Crit Care Med Date: 2001-11-15 Impact factor: 21.405
Authors: Thomas O Carpenter; Jane H Zhang; Esteban Parra; Bruce K Ellis; Christine Simpson; William M Lee; Jody Balko; Lei Fu; Betty Y-L Wong; David E C Cole Journal: J Bone Miner Res Date: 2013-01 Impact factor: 6.741
Authors: Aledie Navas-Nazario; Fang Yong Li; Veronika Shabanova; Pnina Weiss; David E C Cole; Thomas O Carpenter; Alia Bazzy-Asaad Journal: Ann Allergy Asthma Immunol Date: 2014-04-16 Impact factor: 6.347
Authors: Daniel M Albert; Elizabeth A Scheef; Shoujian Wang; Farideh Mehraein; Soesiawati R Darjatmoko; Christine M Sorenson; Nader Sheibani Journal: Invest Ophthalmol Vis Sci Date: 2007-05 Impact factor: 4.799
Authors: Philip L Ballard; Juan Oses-Prieto; Cheryl Chapin; Mark R Segal; Roberta A Ballard; Alma L Burlingame Journal: PLoS One Date: 2020-12-10 Impact factor: 3.240